Performance
Stock factor profile
Beta Drugs Ltd
BETA · Healthcare · Pharmaceuticals & Biotechnology
Beta Drugs Ltd. engages in the manufacturing and trading of pharmaceuticals. The company is headquartered in Panchkula, Haryana. The company went IPO on 2017-10-12. The firm offers a range of oncology products including tablets, capsules and injections. The firm offers a portfolio consisting of approximately 50 products catering to various oncology diseases, including breast, brain, bone, lung, mouth, head and neck, prostate, leukemia, lymphoma and supportive cancer and others. The Company’s oncology portfolio includes various brands, such as AB-PACLI, ADBIRON, ADCARB, ADCIST, Adlante, ADLEAP, ADMIDE, ADOXI, CAPAD, ADTHAL, Triodelta and others.
Equity review factors
Factor profile
Factor scores are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags and screen results for Beta Drugs Ltd are part of the Wright portfolio review.
Run your free portfolio reviewFundamental snapshot
Fundamentals at a glance
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.